Literature DB >> 12909574

Physiological genomic analysis of the brain renin-angiotensin system.

Robin L Davisson1.   

Abstract

The brain renin-angiotensin system (RAS) has long been considered pivotal in cardiovascular regulation and important in the pathogenesis of hypertension and heart failure. However, despite more than 30 years of study, the brain RAS continues to defy explanation. Our lack of understanding of how the brain RAS is organized at the cellular and regional levels has made it difficult to resolve long-sought questions of how ANG II is produced in the brain and the precise mechanisms by which it exerts its actions. A major reason for this is the difficulty in experimentally dissecting the brain RAS at the regional, cellular, and whole organism levels. Recently, we and others developed a series of molecular tools for selective manipulation of the murine brain RAS, in parallel with technologies for integrative analysis of cardiovascular and volume homeostasis in the conscious mouse. This review, based in part on a lecture given in conjunction with the American Physiological Society Young Investigator Award in Regulatory and Integrative Physiology (Water and Electrolyte Homeostasis Section), outlines the physiological genomics strategy that we have taken in an effort to unravel some of the complexities of this system. It also summarizes the principles, progress, and prospects for a better understanding of the brain RAS in health and disease.

Entities:  

Mesh:

Year:  2003        PMID: 12909574     DOI: 10.1152/ajpregu.00190.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  33 in total

1.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

2.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

3.  A new cardiac MASTer switch for the renin-angiotensin system.

Authors:  Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

4.  Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology.

Authors:  Nayaab S Khan; Chi Young Song; Brett L Jennings; Anne M Estes; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

5.  Molecular pathways: radiation-induced cognitive impairment.

Authors:  Dana Greene-Schloesser; Elizabeth Moore; Mike E Robbins
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

Review 6.  Radiation-induced cognitive impairment--from bench to bedside.

Authors:  Dana Greene-Schloesser; Mike E Robbins
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

7.  Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway.

Authors:  Shun-Guang Wei; Yang Yu; Zhi-Hua Zhang; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 8.  The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.

Authors:  Steven D Crowley
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

9.  Enalapril attenuates the exaggerated sympathetic response to physical stress in prenatally programmed hypertensive rats.

Authors:  Masaki Mizuno; German Lozano; Khurrum Siddique; Michel Baum; Scott A Smith
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

10.  Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.

Authors:  Yumei Feng; Huijing Xia; Yanhui Cai; Carmen M Halabi; Lenice K Becker; Robson A S Santos; Robert C Speth; Curt D Sigmund; Eric Lazartigues
Journal:  Circ Res       Date:  2009-11-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.